UK Officials Close to Finalising Deal to Buy Tens of Millions More Doses of Pfizer Vaccine in Time for 3rd Booster Dose for Elderly; Sources Say They Hope to Roughly Double Original Order of 40M
Portfolio Pulse from Charles Gross
UK officials are nearing a deal to purchase tens of millions more doses of the Pfizer vaccine, aiming to double the original order of 40 million doses. This is in preparation for a third booster dose for the elderly.
April 24, 2021 | 11:51 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
BioNTech, as Pfizer's partner in the vaccine, stands to gain from the UK deal to double vaccine orders, enhancing its revenue prospects.
BioNTech, as a partner with Pfizer in the vaccine production, will benefit from increased orders from the UK. This will likely lead to higher revenues and a positive impact on its stock price.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 70
POSITIVE IMPACT
Pfizer is set to benefit from a potential deal with the UK to supply additional vaccine doses, potentially doubling the original order of 40 million doses.
The news of the UK potentially doubling its order of Pfizer vaccines is likely to positively impact Pfizer's stock price in the short term. This deal would increase Pfizer's sales and revenue, especially as it prepares to supply booster doses.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 90